42 related articles for article (PubMed ID: 21031437)
1. The impact of telomere length on prostate cancer aggressiveness, genomic instability and health disparities.
Huang R; Bornman MSR; Stricker PD; Simoni Brum I; Mutambirwa SBA; Jaratlerdsiri W; Hayes VM
Sci Rep; 2024 Apr; 14(1):7706. PubMed ID: 38565642
[TBL] [Abstract][Full Text] [Related]
2. Enhanced induction of abnormal telomere FISH signals in response to oxidative DNA damage.
Sakamoto Y; Shiraishi K; Kodama S
J Radiat Res; 2024 Mar; 65(2):187-193. PubMed ID: 38171574
[TBL] [Abstract][Full Text] [Related]
3. The Relationship between Telomere Length and Nucleoplasmic Bridges and Severity of Disease in Prostate Cancer Patients.
Dhillon VS; Deo P; Fenech M
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444460
[TBL] [Abstract][Full Text] [Related]
4. Integrative epigenome profiling of 47XXY provides insights into whole genomic DNA hypermethylation and active chromatin accessibility.
Miao N; Zeng Z; Lee T; Guo Q; Zheng W; Cai W; Chen W; Wang J; Sun T
Front Mol Biosci; 2023; 10():1128739. PubMed ID: 37051325
[TBL] [Abstract][Full Text] [Related]
5. Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer.
Rybicki BA; Sadasivan SM; Chen Y; Loveless I; Gupta NS; Chitale DA; Williamson SR; Rundle AG; Tang DL
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):991-998. PubMed ID: 35247880
[TBL] [Abstract][Full Text] [Related]
6. Understanding and targeting prostate cancer cell heterogeneity and plasticity.
Tang DG
Semin Cancer Biol; 2022 Jul; 82():68-93. PubMed ID: 34844845
[TBL] [Abstract][Full Text] [Related]
7. Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.
Joshu CE; Heaphy CM; Barber JR; Lu J; Zarinshenas R; Davis C; Han M; Lotan TL; Sfanos KS; De Marzo AM; Meeker AK; Platz EA
Cancer Prev Res (Phila); 2021 Apr; 14(4):463-470. PubMed ID: 33355185
[TBL] [Abstract][Full Text] [Related]
8. Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer Outcomes.
Heaphy CM; Joshu CE; Barber JR; Davis C; Zarinshenas R; De Marzo AM; Lotan TL; Sfanos KS; Meeker AK; Platz EA
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):676-680. PubMed ID: 31915143
[TBL] [Abstract][Full Text] [Related]
9. Influence of In Utero Maternal and Neonate Factors on Cord Blood Leukocyte Telomere Length: Clues to the Racial Disparity in Prostate Cancer?
Weber KA; Heaphy CM; Rohrmann S; Gonzalez B; Bienstock JL; Agurs-Collins T; Platz EA; Meeker AK
Prostate Cancer; 2016; 2016():3691650. PubMed ID: 28070423
[No Abstract] [Full Text] [Related]
10. ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction.
Reddy V; Wu M; Ciavattone N; McKenty N; Menon M; Barrack ER; Reddy GP; Kim SH
J Biol Chem; 2015 Oct; 290(42):25522-33. PubMed ID: 26336104
[TBL] [Abstract][Full Text] [Related]
11. Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial.
Heaphy CM; Gaonkar G; Peskoe SB; Joshu CE; De Marzo AM; Lucia MS; Goodman PJ; Lippman SM; Thompson IM; Platz EA; Meeker AK
Prostate; 2015 Aug; 75(11):1160-6. PubMed ID: 25893825
[TBL] [Abstract][Full Text] [Related]
12. Genomic rearrangements in prostate cancer.
Barbieri CE; Rubin MA
Curr Opin Urol; 2015 Jan; 25(1):71-6. PubMed ID: 25393273
[TBL] [Abstract][Full Text] [Related]
13. Identification of FISH biomarkers to detect chromosome abnormalities associated with prostate adenocarcinoma in tumour and field effect environment.
Zhang Y; Perez T; Blondin B; Du J; Liu P; Escarzaga D; Coon JS; Morrison LE; Pestova K
BMC Cancer; 2014 Feb; 14():129. PubMed ID: 24568597
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Heaphy CM; Yoon GS; Peskoe SB; Joshu CE; Lee TK; Giovannucci E; Mucci LA; Kenfield SA; Stampfer MJ; Hicks JL; De Marzo AM; Platz EA; Meeker AK
Cancer Discov; 2013 Oct; 3(10):1130-41. PubMed ID: 23779129
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional association of androgen receptor with telomeres in prostate cancer cells.
Zhou J; Richardson M; Reddy V; Menon M; Barrack ER; Reddy GP; Kim SH
Aging (Albany NY); 2013 Jan; 5(1):3-17. PubMed ID: 23363843
[TBL] [Abstract][Full Text] [Related]
16. Markers of field cancerization: proposed clinical applications in prostate biopsies.
Trujillo KA; Jones AC; Griffith JK; Bisoffi M
Prostate Cancer; 2012; 2012():302894. PubMed ID: 22666601
[TBL] [Abstract][Full Text] [Related]
17. The potential utility of telomere-related markers for cancer diagnosis.
Heaphy CM; Meeker AK
J Cell Mol Med; 2011 Jun; 15(6):1227-38. PubMed ID: 21352473
[TBL] [Abstract][Full Text] [Related]
18. Topographical analysis of telomere length and correlation with genomic instability in whole mount prostatectomies.
Joshua AM; Shen E; Yoshimoto M; Marrano P; Zielenska M; Evans AJ; Van der Kwast T; Squire JA
Prostate; 2011 May; 71(7):778-90. PubMed ID: 21031437
[TBL] [Abstract][Full Text] [Related]
19. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
Vukovic B; Park PC; Al-Maghrabi J; Beheshti B; Sweet J; Evans A; Trachtenberg J; Squire J
Oncogene; 2003 Apr; 22(13):1978-87. PubMed ID: 12673203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
